HK Stock Market Move | HAIZHI TECH GP (02706) rises by more than 10%, combining the value of AI infrastructure with the growth potential of intelligent body business.
SeaTech Technology Group (02706) surged more than 10%, as of the time of publication, up 10.61% to HK$47.54, with a turnover of HK$1.79 billion.
HAIZHI TECH GP (02706) rose more than 10%, and as of the time of writing, it had risen by 10.61% to reach 47.54 Hong Kong dollars with a trading volume of 1.79 billion Hong Kong dollars.
On the news front, Haizhi Technology recently announced that its wholly-owned subsidiary, Haizhi Xingtu Academician Expert Workstation, has undergone a major strategic upgrade. The workstation has officially shifted its research focus from the high-performance graph computing field to the cutting-edge field of "knowledge graph fusion with large models," and has received official approval from the Beijing Association for Science and Technology. This approval signifies a significant step for Haizhi in building a solid foundation for the application of large models.
Haizhi Technology is a rare AI asset in the Hong Kong stock market that integrates graph fusion, with a market share of 53.3% ranking first in the industry. The company's 2025 financial data shows annual revenue of 621 million yuan, with the Atlas Intelligent Body growing by 68.4% year-on-year, and gross profit margin increasing to 53.2%. The company has achieved an adjusted net profit of 24.15 million yuan, a year-on-year increase of 42.6%, maintaining continuous profitability. CITIC Haitong believes that the company's "graph base + intelligent body application" dual-drive strategy combines the value of industrial AI infrastructure with the growth elasticity of intelligent body business.
Related Articles

Humanwell Healthcare (600079.SH): HW211026 ointment enters Phase II clinical trial research.

HK Stock Market Move | DELTON (01989) increased by over 4% before the close. Net profit in the first half of the year increased by about 90%. The establishment of overseas factories boosted performance.

Guotai Haitong: Build domestic brands to represent high-end Oriental aesthetics. Suggest increasing holdings in MAO GEPING (01318) and others.
Humanwell Healthcare (600079.SH): HW211026 ointment enters Phase II clinical trial research.

HK Stock Market Move | DELTON (01989) increased by over 4% before the close. Net profit in the first half of the year increased by about 90%. The establishment of overseas factories boosted performance.

Guotai Haitong: Build domestic brands to represent high-end Oriental aesthetics. Suggest increasing holdings in MAO GEPING (01318) and others.

RECOMMEND





